FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly novel solid pharmaceutical composition of thelithromycin. Composition includes thelithromycin or one of its addition salts with pharmaceutically acceptable acid as active agent, and microcrystalline cellulose as inert filler with plastic properties.
EFFECT: reduced size of thelithromycin tablet at the same thelithromycin content, increased rupture strength of tablet.
12 cl, 1 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINIG LUMIRACOXIBE | 2002 |
|
RU2329801C2 |
| NEW COMBINED PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT FOR TREATMENT OF CORONAVIRUS INFECTION | 2022 |
|
RU2806643C1 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| COMBINED DRUG FOR VIRAL INFECTION THERAPY | 2017 |
|
RU2662160C9 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
| PHARMACEUTICAL ANTIDIABETIC COMPOSITION BASED ON (+)-CIS-3-(1H-BENZIMIDAZOL-2-YL)-1,2,2-TRIMETHYLCYCLOPENTANE CARBOXYLIC ACID | 2016 |
|
RU2624872C1 |
| PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2316324C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SINGLE ORAL DOSE CONTAINING LEVODOPA, CARBIDOPA AND ENTACAPONE, OR SALTS THEREOF | 2009 |
|
RU2519159C2 |
| TABLETS OF ULIPRISTAL ACETATE | 2009 |
|
RU2492853C2 |
| DOSAGE FORM CONTAINING DESLORATADINE AND METHOD FOR PRODUCING IT | 2013 |
|
RU2550958C2 |
